Open Access Repository
Exploring the Quality of Anticoagulant Prescribed for Patients With Atrial Fibrillation at the St John of God Hawkesbury District Health Centre, New South Wales, Australia
Altmetric
Altmetric
ORCID: 0000-0003-3974-3437 2018
, 'Exploring the Quality of Anticoagulant Prescribed for Patients With Atrial Fibrillation at the St John of God Hawkesbury District Health Centre, New South Wales, Australia'
, Journal of cardiovascular pharmacology and therapeutics
, pp. 1-8
, doi: 10.1177/1074248418786264.
Full text not available from this repository.
Abstract
Background: Limited data are available on the clinical management of atrial fibrillation (AF) and its outcomes from an Australianperspective. Objective: To describe the appropriateness of antithrombotic prescribing for patients who presented with adiagnosis of AF to the Hawkesbury St John of God Hospital, New South Wales, Australia. Methods: This retrospectiveobservational study reviewed patients admitted to St John of God Hawkesbury Hospital with AF between June 2016 and June2017. We calculated stroke risk using the CHA2DS2-VASc score based on medical records and reviewed the appropriateness oforal anticoagulant (OAC) prescribing compared to the 2016 European Society of Cardiology guidelines. Patients were excluded ifthey had only 1 episode of AF that reverted either spontaneously or upon cardioversion without any documented recurrences.Results: A total of 200 patients (18 years) were included, with 180 (90%) deemed eligible for anticoagulation. Of these 72.8% (n ¼131) were prescribed an OAC. A total of 40.0% of patients at low risk of stroke and 68.4% at intermediate risk were prescribed anOAC, respectively. Apixaban was the direct OAC of choice with 36.6% of patients prescribed an OAC receiving apixaban.Warfarin was prescribed for 25.1% of the patients who were prescribed an OAC. Conclusions: The underutilization ofanticoagulant medication in high-risk groups and over utilization in low-risk groups remains an ongoing issue in contemporary AFmanagement, and it highlights the need to improve AF-related stroke prevention in our jurisdiction.
| Item Type: | Article |
|---|---|
| Authors/Creators: | Wertheimer, G and Bereznicki, LR |
| Keywords: | AF, anticoagulants |
| Journal or Publication Title: | Journal of cardiovascular pharmacology and therapeutics |
| Publisher: | Churchill Livingstone Inc. |
| ISSN: | 1074-2484 |
| DOI / ID Number: | 10.1177/1074248418786264 |
| Copyright Information: | Copyright The Author(s) 2018 |
| Related URLs: | |
| Item Statistics: | View statistics for this item |
Actions (login required)
 |
Item Control Page |